calendar
9,798 catalysts · 3,350 8k filing · 2,046 grant · 1,007 approval · 1,000 device adverse event · 732 device 510k · 584 earnings
9,798 catalysts · 3,350 8k filing · 2,046 grant · 1,007 approval · 1,000 device adverse event · 732 device 510k · 584 earnings
HG grant. $1,193,092. PI: Jada Benn Torres
HD grant. $50,526. PI: Cher Sha
NS grant. $128,358. PI: Giulia Carli
ES grant. $5,000,000. PI: Jineta Banerjee
HL grant. $247,600. PI: Cassandra Lucille Clift
HL grant. $249,000. PI: Lisandra Flores Aldama
GM grant. $75,880. PI: Kevin Jaime Gonzalez
DK grant. $75,520. PI: Katherine Lauren Kruckow
DK grant. $676,905. PI: Hai-Bin Ruan
HD grant. $49,538. PI: Charlotte Greenbaum
HL grant. $249,000. PI: Chengyi Tu
HG grant. $806,828. PI: David Martin McCandlish
AI grant. $403,320. PI: Antonius G Oomens
Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: NATCO. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL
Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION
Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL
Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL
Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL
Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL
Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: QILU. Form: INJECTABLE. Route: INJECTION
Product code: MQV. Advisory committee: Orthopedic. Type: Traditional
Product code: QEY. Advisory committee: Cardiovascular. Type: Special
Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional
Product code: MAI. Advisory committee: Orthopedic. Type: Traditional
Product code: FDS. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional
Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional
Supplement type: Normal 180 Day Track. Product code: QZI. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: LPO. Advisory committee: OP. Decision: OK30